BRIEF published on 05/13/2026 at 07:05, 5 months 2 days ago SCHOTT Pharma Reports Resilient First Half and Strong Cash Flow Revenue Growth Cash Flow EBITDA Margin SCHOTT Pharma First Half Results
PRESS RELEASE published on 05/13/2026 at 07:00, 5 months 2 days ago SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow SCHOTT Pharma reports robust first half with strong cash flow, exceeding revenue forecast and confirming full-year outlook for 2026 Financial Results Revenue Cash Flow SCHOTT Pharma H1 2026
BRIEF published on 02/11/2026 at 07:05, 8 months 4 days ago SCHOTT Pharma annonce un bon début d'année 2026 SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
BRIEF published on 02/11/2026 at 07:05, 8 months 4 days ago SCHOTT Pharma Reports a Strong Beginning to 2026 Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
PRESS RELEASE published on 02/11/2026 at 07:00, 8 months 4 days ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF published on 02/03/2026 at 15:05, 8 months 11 days ago All Resolutions Passed at SCHOTT Pharma's AGM Shareholders Dividend Pharmaceutical AGM Resolutions
BRIEF published on 02/03/2026 at 15:05, 8 months 11 days ago Toutes les résolutions ont été adoptées lors de l'assemblée générale annuelle de SCHOTT Pharma. Actionnaires Dividende Resolutions Assemblée Générale Annuelle Pharmaceutique
PRESS RELEASE published on 02/03/2026 at 15:00, 8 months 11 days ago Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved SCHOTT Pharma AG & Co. KGaA had a successful Annual General Meeting with all resolutions approved, including a dividend of 0.18 EUR per share for fiscal year 2025 Annual General Meeting Shareholders Dividend SCHOTT Pharma Resolutions
BRIEF published on 12/11/2025 at 07:05, 10 months 4 days ago SCHOTT Pharma Achieves Full-Year Revenue and Profitability Targets Revenue Growth EBITDA Margin SCHOTT Pharma Drug Delivery Systems Drug Containment Solutions
BRIEF published on 12/11/2025 at 07:05, 10 months 4 days ago SCHOTT Pharma atteint ses objectifs de chiffre d'affaires et de rentabilité pour l'exercice complet. SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Systèmes D'administration De Médicaments Solutions De Confinement Des Médicaments
Published on 10/15/2026 at 08:07, 2 hours 41 minutes ago Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 10/15/2026 at 08:02, 2 hours 46 minutes ago Southern Energy Corp. Announces Successful Cotton Valley Completion Results at Williamsburg
Published on 10/14/2026 at 23:55, 10 hours 53 minutes ago First Helium Announces Strategic Shallow Heavy Oil Acquisition
Published on 10/14/2026 at 23:45, 11 hours 3 minutes ago Polaris Renewable Energy Announces Q3 2026 Investor Call Details
Published on 10/15/2026 at 10:30, 18 minutes ago AI proves its worth in banking - 29 percent would rather talk to AI about sensitive money matters: EOS Group Reports
Published on 10/15/2026 at 10:11, 37 minutes ago EQS-Adhoc: Uniper SE: Supervisory Board reappoints CEO Michael Lewis for a further five-year term
Published on 10/15/2026 at 10:05, 43 minutes ago PANASONIC FC7 LAPTOP DELIVERS PREMIUM MOBILITY, DURABILITY & PERFORMANCE
Published on 10/15/2026 at 10:00, 48 minutes ago invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal
Published on 10/15/2026 at 10:00, 48 minutes ago ESA study on Tipping Points launched: OHB and AWI discuss opportunities for future Earth observation missions
Published on 10/15/2026 at 07:27, 3 hours 21 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
Published on 10/15/2026 at 07:27, 3 hours 21 minutes ago Saint-Gobain renforce son offre pour le marché des infrastructures en Amérique du Nord avec l’acquisition de D.S. Brown dans la chimie de la construction
Published on 10/14/2026 at 18:00, 16 hours 48 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 16 hours 48 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
